|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bi F, Qiu Y, Wu Z, Liu S, Zuo D, Huang Z,
Li B, Yuan Y, Niu Y and Qiu J: METTL9-SLC7A11 axis promotes
hepatocellular carcinoma progression through ferroptosis
inhibition. Cell Death Discov. 9:4282023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang C, Zhang H, Zhang L, Zhu AX, Bernards
R, Qin W and Wang C: Evolving therapeutic landscape of advanced
hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol.
20:203–222. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shokoohian B, Negahdari B, Aboulkheyr Es
H, Abedi-Valugerdi M, Baghaei K, Agarwal T, Maiti TK, Hassan M,
Najimi M and Vosough M: Advanced therapeutic modalities in
hepatocellular carcinoma: Novel insights. J Cell Mol Med.
25:8602–8614. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim HJ, Lee SH, Shim HJ, Bang HJ, Cho SH,
Chung IJ, Hwang EC, Hwang JE and Bae WK: Hepatic arterial infusion
chemotherapy versus systemic therapy for advanced hepatocellular
carcinoma: A systematic review and meta-analysis. Front Oncol.
13:12652402023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sheikholeslami B, Tootoonchi Z, Lavasani
H, Hosseinzadeh Ardakani Y and Rouini M: Investigation of MDMA
inhibitory effect on cytochromeP450 3A4 in isolated perfused rat
liver model using tramadol. Adv Pharm Bull. 11:530–536. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Haduch A, Bromek E, Kuban W,
Basińska-Ziobroń A, Danek PJ, Alenina N, Bader M and Daniel WA: The
effect of brain serotonin deficit (TPH2-KO) on the expression and
activity of liver cytochrome P450 enzymes in aging male Dark Agouti
rats. Pharmacol Rep. 75:1522–1532. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chiang JYL and Ferrell JM: Discovery of
farnesoid X receptor and its role in bile acid metabolism. Mol Cell
Endocrinol. 548:1116182022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shulpekova Y, Shirokova E, Zharkova M,
Tkachenko P, Tikhonov I, Stepanov A, Sinitsyna A, Izotov A, Butkova
T, Shulpekova N, et al: A recent ten-year perspective: Bile acid
metabolism and signaling. Molecules. 27:19832022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen L, Jiao T, Liu W, Luo Y, Wang J, Guo
X, Tong X, Lin Z, Sun C, Wang K, et al: Hepatic cytochrome P450 8B1
and cholic acid potentiate intestinal epithelial injury in colitis
by suppressing intestinal stem cell renewal. Cell Stem Cell.
29:1366–1381.e9. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kaur A, Patankar JV, de Haan W, Ruddle P,
Wijesekara N, Groen AK, Verchere CB, Singaraja RR and Hayden MR:
Loss of Cyp8b1 improves glucose homeostasis by increasing GLP-1.
Diabetes. 64:1168–1179. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pozzo L, Vornoli A, Coppola I, Croce CM,
Giorgetti L, Gervasi PG and Longo V: Effect of HFD/STZ on
expression of genes involved in lipid, cholesterol and glucose
metabolism in rats. Life Sci. 166:149–156. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pathak P and Chiang JYL: Sterol
12α-hydroxylase aggravates dyslipidemia by activating the
ceramide/mTORC1/SREBP-1C pathway via FGF21 and FGF15. Gene Expr.
19:161–173. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hoogerland JA, Lei Y, Wolters JC, de Boer
JF, Bos T, Bleeker A, Mulder NL, van Dijk TH, Kuivenhoven JA, Rajas
F, et al: Glucose-6-phosphate regulates hepatic bile acid synthesis
in mice. Hepatology. 70:2171–2184. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu X, Hong R, Du P, Yang D, He M, Wu Q,
Li L, Wang Y, Chen J, Min Q, et al: The metabolic genomic atlas
reveals potential drivers and clinically relevant insights into the
etiology of esophageal squamous cell carcinoma. Theranostics.
12:6160–6178. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu F, Yu Z, Liu Y, Du T, Yu L, Tian F,
Chen W and Zhai Q: A high-fat, high-cholesterol diet promotes
intestinal inflammation by exacerbating gut microbiome dysbiosis
and bile acid disorders in cholecystectomy. Nutrients. 15:38292023.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu Y, Tu J, Shi L, Fang Z, Fan M, Zhang
J, Ding L, Chen Y, Wang Y, Zhang E, et al: CYP8B1 downregulation
mediates the metabolic effects of vertical sleeve gastrectomy in
mice. Hepatology. 79:1005–1018. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang X, Liao X, Yang C, Huang K, Yu T, Yu
L, Han C, Zhu G, Zeng X, Liu Z, et al: Identification of prognostic
biomarkers for patients with hepatocellular carcinoma after
hepatectomy. Oncol Rep. 41:1586–1602. 2019.PubMed/NCBI
|
|
19
|
Zhang R, Huang M, Wang H, Wu S, Yao J, Ge
Y, Lu Y and Hu Q: Identification of potential biomarkers from
hepatocellular carcinoma with MT1 deletion. Pathol Oncol Res.
27:5975272021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vivian J, Rao AA, Nothaft FA, Ketchum C,
Armstrong J, Novak A, Pfeil J, Narkizian J, Deran AD,
Musselman-Brown A, et al: Toil enables reproducible, open source,
big biomedical data analyses. Nat Biotechnol. 35:314–316. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Y, Li R, Guo S, Li Y, Wang Y, Wen X,
Lan T and Gong K: Bioinformatics-based identification of lipid- and
immune-related biomarkers in abdominal aortic aneurysms. Heliyon.
9:e136222023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li F, Liu CS, Wu P, Ling AS, Pan Q and Li
XN: CCT4 suppression inhibits tumor growth in hepatocellular
carcinoma by interacting with Cdc20. Chin Med J (Engl).
134:2721–2729. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu C, Li F, Li X, Cao M, Feng G, Yuan X
and Shi X: WIPI2 depletion inhibits the growth of hepatocellular
carcinoma cells through the AMPK signaling pathway. Oncol Rep.
43:1467–1478. 2020.PubMed/NCBI
|
|
26
|
Wang W, Chen H, Gao W, Wang S, Wu K, Lu C,
Luo X, Li L and Yu C: Girdin interaction with vimentin induces EMT
and promotes the growth and metastasis of pancreatic ductal
adenocarcinoma. Oncol Rep. 44:637–649. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xing S, Kan J, Su A, Liu QD, Wang K, Cai X
and Dong J: The prognostic value of major facilitator superfamily
domain-containing protein 2A in patients with hepatocellular
carcinoma. Aging (Albany NY). 11:8474–8483. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fu Y, Liu S, Rodrigues RM, Han Y, Guo C,
Zhu Z, He Y, Mackowiak B, Feng D, Gao B, et al: Activation of VIPR1
suppresses hepatocellular carcinoma progression by regulating
arginine and pyrimidine metabolism. Int J Biol Sci. 18:4341–4356.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hu Q, Ma X, Li C, Zhou C, Chen J and Gu X:
Downregulation of THRSP promotes hepatocellular carcinoma
progression by triggering ZEB1 transcription in an ERK-dependent
manner. J Cancer. 12:4247–4256. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu F, Zeng G, Zhou S, He X, Sun N, Zhu X
and Hu A: Blocking Tim-3 or/and PD-1 reverses dysfunction of
tumor-infiltrating lymphocytes in HBV-related hepatocellular
carcinoma. Bull Cancer. 105:493–501. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu J, Carlson HA and Scott EE: The
structure and characterization of human cytochrome P450 8B1
supports future drug design for nonalcoholic fatty liver disease
and diabetes. J Biol Chem. 298:1023442022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Patankar JV, Wong CK, Morampudi V, Gibson
WT, Vallance B, Ioannou GN and Hayden MR: Genetic ablation of
Cyp8b1 preserves host metabolic function by repressing
steatohepatitis and altering gut microbiota composition. Am J
Physiol Endocrinol Metab. 314:E418–E432. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mao Y, Zhao Y, Luo S, Chen H, Liu X, Wu T,
Ding G, Liu X, Sheng J, Meng Y and Huang H: Advanced paternal age
increased metabolic risks in mice offspring. Biochim Biophys Acta
Mol Basis Dis. 1868:1663552022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li X, Khan I, Huang G, Lu Y, Wang L, Liu
Y, Lu L, Hsiao WLW and Liu Z: Kaempferol acts on bile acid
signaling and gut microbiota to attenuate the tumor burden in
ApcMin/+ mice. Eur J Pharmacol. 918:1747732022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mou P, Ge QH, Sheng R, Zhu TF, Liu Y and
Ding K: Research progress on the immune microenvironment and
immunotherapy in gastric cancer. Front Immunol. 14:12911172023.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gan Y, Ye F and He XX: The role of YWHAZ
in cancer: A maze of opportunities and challenges. J Cancer.
11:2252–2264. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sheng N, Yan L, Wu K, You W, Gong J, Hu L,
Tan G, Chen H and Wang Z: TRIP13 promotes tumor growth and is
associated with poor prognosis in colorectal cancer. Cell Death
Dis. 9:4022018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ma J, Chen W, Wang K, Tian K, Li Q, Zhao
T, Zhang L, Wang L, Wu Z and Zhang J: Identification of the
different roles and potential mechanisms of T isoforms in the tumor
recurrence and cell cycle of chordomas. Onco Targets Ther.
12:11777–11791. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Guo F, Jiao D, Sui GQ, Sun LN, Gao YJ, Fu
QF and Jin CX: Anticancer effect of YWHAZ silencing via inducing
apoptosis and autophagy in gastric cancer cells. Neoplasma.
65:693–700. 2018. View Article : Google Scholar : PubMed/NCBI
|
